$WSBC

Executive Sheds Over 3,000 Shares of Regional Bank, in Transaction Valued at More Than $125,000

WesBanco Director Denise H. Knouse-Snyder sold 3,070 shares (17% of her stake) at $40.89 each on Aug. 24, 2026. She now holds 15,035 shares. WesBanco has a $3.9B market cap, $356M TTM net income, and operates in community banking and trust services. The stock has underperformed the S&P 500 over 5 years but is near a 52-week high.

Original reporting
Published Aug 28, 2026, 5:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 5:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Executive Sheds Over 3,000 Shares of Regional Bank, in Transaction Valued at More Than $125,000 — source image
Decision brief

The 30-second read

$WSBCBearishLow
01

Why it matters

Provides fresh data on insider holdings, offering insight into potential short‑term price moves.

02

Market read

Insider transaction adds modest new information for traders monitoring WSBC and regional banks.

03

What to watch

Strong recent earnings and near‑52‑week high may offset any negative sentiment.

Relevance 4/10Novelty 4/10Timing: post‑Form 4 filing Aug 24

Background

The article reports a recent SEC Form 4 filing where a WesBanco director sold shares.

Company-level read

Ticker impact

$WSBCBearishMedium confidence
Context

Director Denise H. Knouse‑Snyder sold 3,070 WSBC shares (~$125k), cutting her stake by 17% to 15,035 shares.

Expected impact

Potential short‑term dip of 1‑2% as market digests the sale.

Evidence & confidence

Director sales of this size are routine but a 17% stake reduction could prompt cautious trading.

Market effects

Regional banking sector may see heightened scrutiny of insider activity.

Limited impact on broader Mid‑Atlantic banking markets.

Minimal; effect confined to WSBC and similar U.S. regional banks.

Counterpoint

Insider sale could be routine tax planning, not a bearish signal.

Key entities

  • Denise H. Knouse‑Snyder

    Director at WesBanco who sold 3,070 shares.

  • WesBanco, Inc.

    Regional financial services holding company (ticker WSBC).

Related articles

$WSBCMed

WesBanco Announces Second Quarter 2026 Financial Results

WesBanco, Inc. (Nasdaq: WSBC) reported Q2 2026 net income of $88.4 million and diluted EPS of $0.91, versus $54.9 million and $0.57 in Q2 2025. For six months ended June 30, 2026, net income was $172.8 million and diluted EPS $1.79. The bank cited 8.3% annualized loan growth, NIM of 3.63%, and an efficiency ratio of 51.2%.

$WSBCMed

WESBANCO INC (WSBC): Results of Operations and Financial Condition

WESBANCO INC (WSBC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 wsbc-ex99_1.htm EX-99.1 EX-99.1 WesBanco Announces Second Quarter 2026 Financial Results Marked by strong annualized loan growth, top-tier efficiency ratio, and accelerating growth in targeted expansion markets Wheeling, WVa. (July 21, 2026) – WesBanco, Inc. (“WesBanco”

$WSBCLow

WESBANCO INC (WSBC): Results of Operations and Financial Condition

WESBANCO INC (WSBC) filed an SEC Form 8-K — Results of Operations and Financial Condition. 8-K 0000203596 false 0000203596 us-gaap:SeriesBPreferredStockMember 2026-07-02 2026-07-02 0000203596 us-gaap:CommonStockMember 2026-07-02 2026-07-02 0000203596 2026-07-02 2026-07-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pu

$BKRMed

Baker Hughes Awarded Offshore Production Enhancement and Stimulation Services Contract by bp

Baker Hughes (BKR) secured a contract from bp (BP) to provide offshore stimulation services in the UK North Sea, supporting new well development and enhanced recovery. The deal involves a vessel-based solution for efficient well completions and production enhancement, aiming to improve operational reliability and reservoir recovery. Baker Hughes will leverage its StimFORCE modular stimulation package and local supply chain network.

$TEVAMed

S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline

S&P Global Ratings upgraded Teva Pharmaceutical's long-term issuer credit rating to BBB- from BB+, reflecting strong financial performance and debt reduction. This is the third upgrade in recent months, with Teva now holding investment-grade ratings from all major agencies. The company's CFO attributed the upgrades to successful execution of its growth strategy and improved financial profile.

$MOMOMed

StoneX cuts Hello Group stock price target on weaker outlook

StoneX reduced its price target for Hello Group (MOMO) to $8.00 from $10.00, citing weaker domestic spending and moderating overseas growth. The company's Q2 2026 revenue declined 5% YoY, though overseas revenue grew 52% YoY. StoneX lowered its fiscal 2026 revenue forecast to a 6% YoY decline. Hello Group's stock trades at $5.39, near its 52-week low, with a P/E ratio of 8.34 and a 5.1% dividend yield.